214 related articles for article (PubMed ID: 21906275)
1. Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence.
Wilcock DM; Morgan D; Gordon MN; Taylor TL; Ridnour LA; Wink DA; Colton CA
J Neuroinflammation; 2011 Sep; 8():115. PubMed ID: 21906275
[TBL] [Abstract][Full Text] [Related]
2. Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses.
Wilcock DM; Zhao Q; Morgan D; Gordon MN; Everhart A; Wilson JG; Lee JE; Colton CA
ASN Neuro; 2011 Nov; 3(5):249-58. PubMed ID: 21995345
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid.
Wilcock DM; Jantzen PT; Li Q; Morgan D; Gordon MN
Neuroscience; 2007 Feb; 144(3):950-60. PubMed ID: 17137722
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages.
Asuni AA; Boutajangout A; Scholtzova H; Knudsen E; Li YS; Quartermain D; Frangione B; Wisniewski T; Sigurdsson EM
Eur J Neurosci; 2006 Nov; 24(9):2530-42. PubMed ID: 17100841
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy reduces vascular amyloid-beta in PDAPP mice.
Schroeter S; Khan K; Barbour R; Doan M; Chen M; Guido T; Gill D; Basi G; Schenk D; Seubert P; Games D
J Neurosci; 2008 Jul; 28(27):6787-93. PubMed ID: 18596154
[TBL] [Abstract][Full Text] [Related]
7. Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease.
Wilcock DM; Gharkholonarehe N; Van Nostrand WE; Davis J; Vitek MP; Colton CA
J Neurosci; 2009 Jun; 29(25):7957-65. PubMed ID: 19553436
[TBL] [Abstract][Full Text] [Related]
8. Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage.
Nikolic WV; Bai Y; Obregon D; Hou H; Mori T; Zeng J; Ehrhart J; Shytle RD; Giunta B; Morgan D; Town T; Tan J
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2507-12. PubMed ID: 17264212
[TBL] [Abstract][Full Text] [Related]
9. Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.
Cribbs DH
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):207-16. PubMed ID: 20205639
[TBL] [Abstract][Full Text] [Related]
10. Reduced Efficacy of Anti-Aβ Immunotherapy in a Mouse Model of Amyloid Deposition and Vascular Cognitive Impairment Comorbidity.
Weekman EM; Sudduth TL; Caverly CN; Kopper TJ; Phillips OW; Powell DK; Wilcock DM
J Neurosci; 2016 Sep; 36(38):9896-907. PubMed ID: 27656027
[TBL] [Abstract][Full Text] [Related]
11. Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities.
Zago W; Schroeter S; Guido T; Khan K; Seubert P; Yednock T; Schenk D; Gregg KM; Games D; Bard F; Kinney GG
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S105-15. PubMed ID: 23583235
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice.
Luo F; Rustay NR; Seifert T; Roesner B; Hradil V; Hillen H; Ebert U; Severin JM; Cox BF; Llano DA; Day M; Fox GB
J Pharmacol Exp Ther; 2010 Dec; 335(3):580-8. PubMed ID: 20823195
[TBL] [Abstract][Full Text] [Related]
13. [Aβ immunotherapy for Alzheimer's disease].
Sakai K; Yamada M
Brain Nerve; 2013 Apr; 65(4):461-8. PubMed ID: 23568994
[TBL] [Abstract][Full Text] [Related]
14. The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects.
Wiessner C; Wiederhold KH; Tissot AC; Frey P; Danner S; Jacobson LH; Jennings GT; Lüönd R; Ortmann R; Reichwald J; Zurini M; Mir A; Bachmann MF; Staufenbiel M
J Neurosci; 2011 Jun; 31(25):9323-31. PubMed ID: 21697382
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1.
Ridnour LA; Dhanapal S; Hoos M; Wilson J; Lee J; Cheng RY; Brueggemann EE; Hines HB; Wilcock DM; Vitek MP; Wink DA; Colton CA
J Neurochem; 2012 Dec; 123(5):736-49. PubMed ID: 23016931
[TBL] [Abstract][Full Text] [Related]
16. 'Clinical trials in Alzheimer's disease': immunotherapy approaches.
Delrieu J; Ousset PJ; Caillaud C; Vellas B
J Neurochem; 2012 Jan; 120 Suppl 1():186-193. PubMed ID: 21883222
[TBL] [Abstract][Full Text] [Related]
17. Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer's disease.
Chauhan NB; Siegel GJ
Expert Rev Vaccines; 2004 Dec; 3(6):717-25. PubMed ID: 15606357
[TBL] [Abstract][Full Text] [Related]
18. Anti-Amyloid-β Single-Chain Antibody Brain Delivery Via AAV Reduces Amyloid Load But May Increase Cerebral Hemorrhages in an Alzheimer's Disease Mouse Model.
Kou J; Kim H; Pattanayak A; Song M; Lim JE; Taguchi H; Paul S; Cirrito JR; Ponnazhagan S; Fukuchi K
J Alzheimers Dis; 2011; 27(1):23-38. PubMed ID: 21709371
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease.
Minami SS; Sidahmed E; Aid S; Shimoji M; Niikura T; Mocchetti I; Rebeck GW; Prendergast JS; Dealwis C; Wetzel R; Bosetti F; Matsuoka Y; Hoe HS; Turner RS
J Neuroinflammation; 2010 Sep; 7():57. PubMed ID: 20920207
[TBL] [Abstract][Full Text] [Related]
20. An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.
Adolfsson O; Pihlgren M; Toni N; Varisco Y; Buccarello AL; Antoniello K; Lohmann S; Piorkowska K; Gafner V; Atwal JK; Maloney J; Chen M; Gogineni A; Weimer RM; Mortensen DL; Friesenhahn M; Ho C; Paul R; Pfeifer A; Muhs A; Watts RJ
J Neurosci; 2012 Jul; 32(28):9677-89. PubMed ID: 22787053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
